Advertisement

Psychopharmacology

, Volume 96, Issue 3, pp 421–425 | Cite as

Physostigmine improves water maze performance following nucleus basalis magnocellularis lesions in rats

  • R. J. Mandel
  • L. J. Thal
Original Investigations

Abstract

Bilateral excitotoxic lesions of the nucleus basalis magnocellularis in rats were used along with testing in the water maze task to assess whether inhibition of acetylcholinesterase with physostigmine would reverse the lesion-induced impairment. Rats were lesioned bilaterally in stages using ibotenic acid and then behaviorally tested 3 weeks after surgery. Lesioned animals were administered one of three doses of physostigmine (0.06, 0.19, or 0.32 mg/kg) or vehicle solution 15 min prior to water maze testing. Sham lesioned animals injected with vehicle solution served as an untreated control group. Animals were tested for 5 consecutive days followed by 2 days off and then tested for 5 additional days. The rats were then sacrificed and their frontal cortex was assayed for choline acetyltransferase. The nucleus basalis magnocellularis lesion caused approximately a 27% depletion of choline acetyltransferase in the frontal cortex of these animals. The lesion also impaired the performance of the rats given vehicle solution as compared to untreated controls. Two doses (0.06 and 0.19 mg/kg) of physostigmine improved performance relative to lesioned controls. The lower dose, 0.06 mg/kg, improved performance more than the 0.19 mg/kg dose of physostigmine. The highest dose of physostigmine impaired water maze performance relative to lesioned controls. These data are discussed in relation to the cholinergic hypothesis of Alzheimer's disease and the potential therapeutic use of physostigmine.

Key words

Alzheimer's disease Cholinergic Water maze Physostigmine Spatial learning 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Altman RT, Crosland RD, Jenden DJ, Berman RF (1985) Further characterizations of the nature of the behavioral and neurochemical effects of lesions to the nucleus basalis of Meynert in the rat. Neurobiol Aging 6:125–130Google Scholar
  2. Bartus RT, Dean RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408–417Google Scholar
  3. Bartus RT, Flicker C, Dean RL, Pontecorvo M, Figueiredo JC, Fisher SK (1985) Selective memory loss following nucleus basalis lesions: long-term behavioral recovery despite persistent cholinergic deficiencies. Pharmacol Biochem Behav 23:125–135Google Scholar
  4. Dokla CPJ, Thal LJ (1988) Effect of cholinesterase inhibitors on Morris water-task behavior following lesions of the nucleus basalis magnocellularis. Behav Neurosci (in press)Google Scholar
  5. Dunnett SB, Tonolio G, Fine A, Ryan CN, Björklund A, Iversen SD (1985) Transplantation of embryonic ventral forebrain neurons to the neocortex of rats with lesions of the nucleus basalis magnocellularis: II. Sensorimotor and learning impairments. Neuroscience 16:787–797Google Scholar
  6. Everitt BJ, Robbins TW, Evenden JL, Marston HM, Jones GH, Sirkia TE (1987) The effects of excitotoxic lesions of the substantia innominata, ventral and dorsal globus pallidus on the acquisition and retention of a conditional visual discrimination: Implications for cholinergic hypotheses of learning and memory. Neuroscience 22:441–469Google Scholar
  7. Fisher A, Heldman E, Brandeis R, Pittel Z, Dachir S, Levy A, Karton I (1986) AF102B: a novel putative M1 agonist reverses AF64A-induced cognitive impairments in rats. Soc Neurosci Abstr 12:702Google Scholar
  8. Flicker C, Dean RL, Watkins DL, Fisher SK, Bartus RT (1983) Behavioral and neurochemical effects following neurotoxic lesions of a major cholinergic input to the cerebral cortex in the rat. Pharmacol Biochem Behav 18:973–981Google Scholar
  9. Flood JF, Landry DW, Jarvik ME (1981) Cholinergic receptor interactions and their effects on long-term memory processing. Brain Res 215:177–185Google Scholar
  10. Fonnum F (1969) Radiochemical microassays for the determination of choline acetyltransferase and acetylcholinesterase activities. J Biochem 115:465–472Google Scholar
  11. Friedman E, Lerer B, Kuster J (1983) Loss of cholinergic neurons in the rat neocortex produces deficits in passive avoidance learning. Pharmacol Biochem Behav 19:309–312Google Scholar
  12. Hagan JJ, Tweedie F, Morris RGM (1986) Lack of task specificity and absence of posttraining effects of atropine on learning. Behav Neurosci 100:483–493Google Scholar
  13. Haroutunian V, Kanof P, Davis KL (1985) Pharmacological alleviation of cholinergic lesion induced memory deficits in rats. Life Sci 37:945–952Google Scholar
  14. Hepler DJ, Wenk GL, Cribbs BL, Olton DS, Coyle JT (1985) Memory impairments following basal forebrain lesions. Brain Res 346:8–14Google Scholar
  15. Kessler J, Markowitsch HJ, Sigg G (1986) Memory related role of the posterior cholinergic system. Int J Neurosci 30:101–119Google Scholar
  16. Lerer B, Warner J (1986) Radial maze performance deficits following lesions of rat basal forebrain. In: A Fisher, I Hanin, C Lachman (eds) Advances in behavioral biology, vol 29. Plenum Press, New York, pp 419–426Google Scholar
  17. Mandel RJ, Gage FH, Thal LJ (1987) The effect of training schedule in the Morris water maze on rats with nucleus basalis lesions. Soc Neurosci Abstr 13:646Google Scholar
  18. Miyamoto M, Shintani M, Nagaoka A, Nagawa Y (1985) Lesioning of the rat basal forebrain leads to memory impairments in passive and active avoidance tasks. Brain Res 328:97–104Google Scholar
  19. Murray CL, Fibiger HC (1985) Learning and memory deficits after lesions of the nucleus basalis magnocellularis: reversal by physostigmine. Neuroscience 14:1025–1032Google Scholar
  20. Murray CL, Fibiger HC (1986) Pilocarpine and physostigmine attenuate spatial memory impairments produced by lesions of the nucleus basalis magnocellularis. Behav Neurosci 100:23–32Google Scholar
  21. Pearson RCA, Sofroniew MV, Cuello AC, Powell TPS, Eckenstein F, Esiri MM, Wilcock GK (1983) Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase. Brain Res 289:375–379Google Scholar
  22. Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 2:1457–1459Google Scholar
  23. Sims NR, Bowen DM, Allen SJ, Smith CCT, Neary D, Thomas DJ, Davison AN (1983) Presynaptic cholinergic dysfunction in patients with dementia. J Neurochem 40:503–509Google Scholar
  24. Thal LJ, Fuld PA, Masur DM, Sharpless NS (1983) Oral physostigmine and lecithin improve memory in Alzheimer disease. Ann Neurol 13:491–496Google Scholar
  25. Thal LJ, Dokla CPJ, Armstrong DM (1988) Nucleus basalis lesions: biochemical and immunocytochemical recovery and effect of cholinesterase inhibitors on passive avoidance. Behav Neurosci (in press)Google Scholar
  26. Whishaw IW, O'Conner WT, Dunnett SB (1985) Disruption of central cholinergic systems in the rat by basal forebrain lesions or atropine: effects on feeding, sensorimotor behavior, locomotor activity and spatial navigation. Behav Brain Res 17:103–115Google Scholar
  27. Whitehouse PJ, Price DL, Clark AW, Coyle JT (1981) Alzheimer's disease: evidence for selective loss of cholinergic neurons in nucleus basalis. Ann Neurol 10:122–126PubMedGoogle Scholar
  28. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, DeLong MR (1982) Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215:1237–1239Google Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • R. J. Mandel
    • 1
    • 2
  • L. J. Thal
    • 1
  1. 1.Neurology ServiceVeterans Administration Medical CenterSan DiegoUSA
  2. 2.Department of NeurosciencesUniversity of CaliforniaSan Diego/La JollaUSA

Personalised recommendations